Table 1. Association between miR-27a protein expression and clinicopathological features of patients with BC.
Clinicopathological feature | Case | miR-27a protein expression | P |
---|---|---|---|
Age of onset | 0.337 | ||
≤ 55 years old | 217 | 2.056 ± 0.710 | |
> 55 years old | 179 | 2.126 ± 0.735 | |
Menstruation condition | 0.450 | ||
Premenopausal | 211 | 2.062 ± 0.708 | |
Postmenopausal | 185 | 2.117 ± 0.737 | |
Clinical stages | < 0.001 | ||
I stage | 38 | 1.381 ± 0.093 | |
II stage | 235 | 1.817 ± 0.647 | |
III stage | 123 | 2.823 ± 0.192 | |
Tumor size | < 0.001 | ||
≤ 2 cm | 207 | 1.862 ± 0.246 | |
> 2 cm | 189 | 1.921 ± 0.240 | |
Lymph node metastasis | < 0.001 | ||
Yes | 186 | 2.808 ± 0.228 | |
No | 210 | 1.450 ± 0.259 | |
Distant metastasis | < 0.001 | ||
Yes | 118 | 2.857 ± 0.065 | |
No | 278 | 1.761 ± 0.618 |
Note: miR-27a, microRNA-27a; BC, breast cancer.